InnoCare Pharma Ltd. (HK:9969) has released an update.
InnoCare Pharma Ltd. has announced the resignations of Mr. Ming Jin, a non-executive Director, and Dr. Kaixian Chen, an independent non-executive Director and a member of multiple board committees, effective from 25 September 2024. The company thanked them for their service and confirmed there were no disagreements or undisclosed matters related to their departures. In the wake of these changes, Dr. Dandan Dong has been appointed to the vacated committee roles, and the company is seeking a new independent non-executive Director to comply with listing rules.
For further insights into HK:9969 stock, check out TipRanks’ Stock Analysis page.
